NCT05628207 Evaluation of the SCALED (SCaling AcceptabLE cDs)
| NCT ID | NCT05628207 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Traumatic Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2023-05-16 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2023-05-16 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previously implementing this guideline. The Our overall goal is to successfully scale, evaluate, and maintain an interoperable TBI CDS across 7 total institutions.
Eligibility Criteria
Inclusion Criteria: * age 18 and older * admitted with a TBI Exclusion Criteria: * Patients who die within 24 hours of hospital admission and patients documented as "comfort cares" during the first 72 hours of hospitalization or with mild TBI will be excluded from final analysis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05628207 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05628207 currently recruiting?
Yes, NCT05628207 is actively recruiting participants. Contact the research team at ctignane@umn.edu for enrollment information.
Where is the NCT05628207 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT05628207 clinical trial?
NCT05628207 is sponsored by University of Minnesota. The trial plans to enroll 15,000 participants.